Overcoming analytical challenges to generate data critical to understanding lipid nanoparticle-delivered modified

Glen Hawthorne1, Neil Henderson2, Mikko Hölttä2

  • 1Translational Biomarkers and Bioanalysis, Clinical Pharmacology Biologics & Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Bioanalysis
|October 17, 2019
PubMed